A detailed history of Bleakley Financial Group, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 1,898 shares of NTRA stock, worth $319,718. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,898
Previous 2,215 14.31%
Holding current value
$319,718
Previous $240 Million 0.45%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$97.75 - $129.67 $30,986 - $41,105
-317 Reduced 14.31%
1,898 $241 Million
Q2 2024

Aug 12, 2024

SELL
$85.28 - $112.6 $18,761 - $24,772
-220 Reduced 9.03%
2,215 $240 Million
Q1 2024

May 08, 2024

BUY
$59.21 - $92.9 $144,176 - $226,211
2,435 New
2,435 $223 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.